Home page Home page
AstraZeneca

Evotaz
atazanavir, cobicistat

Package leaflet: Information for the user


EVOTAZ 300 mg/150 mg film-coated tablets

atazanavir/cobicistat


Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Tablet core - cellulose, microcrystalline (E460(i)), croscarmellose sodium (E468), sodium starch glycolate, crospovidone (E1202), stearic acid (E570), magnesium stearate (E470b), hydroxypropyl cellulose (E463), silica (E551)

Film-coating - hypromellose (hydroxypropyl methyl cellulose, E464), titanium dioxide (E171),

talc (E553b), triacetin (E1518), red iron oxide (E172)


What EVOTAZ looks like and contents of the pack

EVOTAZ film-coated tablets are pink, oval, biconvex, of approximate dimensions of

19 mm x 10.4 mm, debossed on one side with "3641" and plain-faced on the other side of the tablet.


EVOTAZ film-coated tablets are supplied in bottles of 30 tablets. The following pack sizes are available: outer cartons containing 1 bottle of 30 film-coated tablets and outer cartons containing 90 (3 bottles of 30) film-coated tablets.


Not all packages may be marketed in your country.


Marketing Authorisation Holder Bristol-Myers Squibb Pharma EEIG Plaza 254

Blanchardstown Corporate Park 2 Dublin 15, D15 T867

Manufacturer

CATALENT ANAGNI S.R.L.

Loc. Fontana del Ceraso snc Strada Provinciale 12 Casilina, 41

03012 Anagni (FR)

Ireland Italy


Swords Laboratories Unlimited Company T/A Bristol-Myers Squibb Pharmaceutical Operations, External Manufacturing

Plaza 254

Blanchardstown Corporate Park 2 Dublin 15, D15 T867

Ireland


image

For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:


This leaflet was last revised in

.